J&J’s Clinical Data Disclosure Strategy Focuses On Collaboration With Yale University Group
This article was originally published in The Pink Sheet Daily
Executive Summary
In what appears to be the most expansive policy to date on release of clinical trial data, J&J will use an existing outside group and will share full clinical study reports and patient-level data regardless of when the studies were conducted.